Castle Biosciences, Inc.CSTLNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank25
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P25
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-0.80%
20241252.97%
202386.49%
2022-119.43%
2021-292.43%
202040.63%
2019157.06%
2018-0.50%
20170.00%